Winston Pharmaceuticals, Inc.
WPHM · OTC
3/31/2010 | 12/31/2009 | 9/30/2009 | 6/30/2009 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -6.6% | -3.3% | -4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -145.1% | -165.2% | -199.9% | -187.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -145.5% | -165.7% | -200.4% | -167.7% |
| EPS Diluted | -0.01 | 0 | -0.01 | -0.01 |
| % Growth | – | 100% | 0% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |